Foghorn Therapeutics Inc. Defined Contribution Plan, Cost
Foghorn Therapeutics Inc. (FHTX) reported Defined Contribution Plan, Cost of $300.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-03-11
- Foghorn Therapeutics Inc. defined contribution plan, cost for the quarter ending 2023-06-30 was $200.00K.
- Foghorn Therapeutics Inc. defined contribution plan, cost for the quarter ending 2023-03-31 was $200.00K.
- Foghorn Therapeutics Inc. defined contribution plan, cost for the quarter ending 2022-06-30 was $0.00.
- Foghorn Therapeutics Inc. defined contribution plan, cost for fiscal 2025 was $300.00K, a 0.00% change from fiscal 2024.
- Foghorn Therapeutics Inc. defined contribution plan, cost for fiscal 2024 was $300.00K, a 25.00% decline from fiscal 2023.
- Foghorn Therapeutics Inc. defined contribution plan, cost for fiscal 2023 was $400.00K.
- Foghorn Therapeutics Inc. defined contribution plan, cost for fiscal 2022 was $0.00.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|
| 2025-12-31 | $300.00K 10-K · filed 2026-03-11 | ||
| 2024-12-31 | $300.00K 10-K · filed 2026-03-11 | ||
| 2023-12-31 | $400.00K 10-K · filed 2025-03-06 | ||
| 2023-06-30 | $200.00K 10-Q · filed 2023-08-04 | $400.00K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $200.00K 10-Q · filed 2023-05-08 | ||
| 2022-12-31 | $0.00 10-K · filed 2024-03-07 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |